News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Kang Sheng Bao to Develop Immune System Diagnostic Test for SuperNova Diagnostics



3/30/2011 12:44:35 PM

March 30, 2011 -- Shenzhen Kang Sheng Bao Bio-Technology has signed an agreement with SuperNova Diagnostics®, a Washington DC development stage company, giving KSB the responsibility to develop, manufacture and market diagnostic products that measure neopterin. Neopterin is a biomarker of immune system activity. KSB will use SuperNova’s AmpCrystal® platform. Two weeks ago, KSB and SuperNova announced KSB had licensed China rights for SuperNova’s platform. More details....

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES